シミズ キヨウコ   SHIMIZU Kyoko
  清水 京子
   所属   その他 その他
   職種   非常勤嘱託
論文種別 総説
言語種別 英語
査読の有無 査読なし
表題 Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020.
掲載誌名 正式名:Journal of gastroenterology
略  称:J Gastroenterol
ISSNコード:14355922/09441174
掲載区分国内
巻・号・頁 57(4),pp.225-245
著者・共著者 OKAZAKI Kazuichi, KAWA Shigeyuki, KAMIZAWA Terumi, IKEURA Tsukasa, ITOI Takao, ITO Tetsuhide, INUI Kazuo, IRISAWA Atsushi, UCHIDA Kazushige, OHARA Hirotaka, KUBOTA Kensuke, KODAMA Yuzo, SHIMIZU Kyoko, TONOZUKA Ryosuke, NAKAZAWA Takahiro, NISHINO Takayoshi, NOROHARA Kenji, FUJINAGA Yasunari, MASAMUNE Atsushi, YAMAMOTO Hiroshi, WATANABE Takayuki, NISHIYAMA Toshimasa, KAWANO Mitsuhiro, SHIRATORI Keiko, SHIMOSEGAWA Tooru, TAKEYAMA Yoshifumi,
発行年月 2022/04
概要 In response to the latest knowledge and the amendment of the Japanese diagnostic criteria for autoimmune pancreatitis (AIP) in 2018, the Japanese consensus guidelines for managing AIP in 2013 were required to be revised. Three committees [the professional committee for developing clinical questions (CQs) and statements by Japanese specialists; the expert panelist committee for rating statements by the modified Delphi method; and the evaluating committee of moderators] were organized. Twenty specialists in AIP extracted the specific clinical statements from a total of 5218 articles (1963-2019) from a search in PubMed and the Cochrane Library. The professional committee made 14, 9, 5, and 11 CQs and statements for the current concept and diagnosis, extra-pancreatic lesions, differential diagnosis, and treatment, respectively. The expert panelists regarded the statements as valid after a two-round modified Delphi approach with individually rating these clinical statements, in which a clinical statement receiving a median score greater than 7 on a 9-point scale from the panel was regarded as valid. After evaluation by the moderators, the amendment of the Japanese consensus guidelines for AIP has been proposed in 2020.
DOI 10.1007/s00535-022-01857-9
PMID 35192048